You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
2026 › March › 19
Lilly
4 months ago
The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.
Eli Lilly’s next-generation obesity drug retatrutide clears first late-stage diabetes trial ⊖
Lilly is betting big on retatrutide as the next pillar of its obesity portfolio after its weight loss injection Zepbound and its upcoming pill, orforglipron.
page 1 of 1